Holen Sie sich die Stockscreener-App
86.60
1.70%
-1.50
Finanzdaten der Edwards Lifesciences Corp-Aktie (EW)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
5.60%
1,741.00
|
1,648.60 | 1,569.60 | 1,553.10 | 1,532.20 |
| Cost Of Revenue |
8.22%
392.40
|
362.60 | 343.00 | 345.20 | 344.40 |
| Gross Profit |
4.87%
1,348.60
|
1,286.00 | 1,226.60 | 1,207.90 | 1,187.80 |
Selling, General, and Administrative
|
7.47%
561.20
|
522.20 | - | - | - |
| Operating Income/Loss |
7.45%
513.20
|
477.60 | 151.10 | 307.10 | 411.20 |
| Net Interest Income/Expense |
10.45%
30.00
|
33.50 | -132.90 | 38.60 | 37.40 |
| Nonoperating Income/Loss |
135.48%
6.60
|
-18.60 | -60.70 | 41.30 | -11.00 |
| Income/Loss From Continuing Operations Before Tax |
13.25%
519.80
|
459.00 | 90.40 | 348.40 | 400.20 |
| Income Tax Expense/Benefit |
255.56%
278.40
|
78.30 | 26.20 | 56.10 | 64.30 |
| Income/Loss From Continuing Operations After Tax |
36.59%
241.40
|
380.70 | 64.20 | 292.30 | 335.90 |
| Income/Loss From Discontinued Operations, Net Of Tax |
-
|
- | 27.00 | -2.00 | -4.40 |
| Net Income/Loss |
36.59%
241.40
|
380.70 | 91.20 | 290.30 | 331.50 |
| Attributable To Noncontrolling Interest |
-0.50
|
- | - | -0.80 | -1.70 |
| Basic Average Shares |
0.48%
576.40
|
579.20 | -1.40 | 584.70 | 587.00 |
| Diluted Average Shares |
0.53%
577.60
|
580.70 | -1.40 | 585.70 | 587.90 |
| Basic Earnings Per Share |
36.36%
0.42
|
0.66 | 0.16 | 0.50 | 0.57 |
| Diluted Earnings Per Share |
36.36%
0.42
|
0.66 | 0.16 | 0.50 | 0.56 |
0.57%
1.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):